🎁 Black Friday: up to 50% off of annual plans
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.200
-0.140 (-5.98%)
At close: Nov 20, 2026, 4:00 PM EST
2.298
+0.098 (4.47%)
After-hours: Nov 20, 2026, 7:59 PM EST

Ovid Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13.8113.1526.327.0444.87187.8
Short-Term Investments
122.7956.4826.7778.7984.13-
Cash & Short-Term Investments
136.669.6453.08105.83129187.8
Cash Growth
433.54%31.20%-49.85%-17.96%-31.31%160.71%
Prepaid Expenses
5.364.732.873.762.382.68
Other Current Assets
---0--
Total Current Assets
141.9674.3755.94109.6131.38190.48
Property, Plant & Equipment
10.8411.8613.2314.6616.070.24
Long-Term Investments
67.5162.7720.9717.635.621.63
Other Intangible Assets
--0.090.20.220.26
Other Long-Term Assets
1.931.931.931.941.971.93
Total Assets
222.24150.9392.17144.03155.27194.54

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.861.963.193.71.957.13
Accrued Expenses
4.364.95.996.524.57.67
Current Portion of Leases
1.511.431.341.250.53-
Total Current Liabilities
11.868.2910.5211.476.9914.8
Long-Term Leases
10.8411.9913.4214.7616-
Other Long-Term Liabilities
0.87--30--
Total Liabilities
23.5720.2723.9456.2322.9914.8

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.190.130.070.070.070.07
Additional Paid-In Capital
574452.45372.49365.59357.77351.03
Retained Earnings
-374.49-321.71-304.3-277.87-225.53-171.36
Comprehensive Income & Other
-1.03-0.2-0.04--0.04-
Total Common Equity
198.67130.6668.2387.8132.27179.75
Shareholders' Equity
198.67130.6668.2387.8132.27179.75
Total Liabilities & Equity
222.24150.9392.17144.03155.27194.54

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
12.3513.4214.761616.54-
Net Cash (Debt)
149.0777.0338.3289.83112.47187.8
Net Cash Growth
1159.00%101.01%-57.34%-20.13%-40.11%160.71%
Net Cash Per Share
0.961.040.541.271.602.76
Filing Date Shares Outstanding
188.73131.8771.0870.7170.4970.37
Total Common Shares Outstanding
188.72130.1871.0170.6970.4770.36
Working Capital
130.166.0845.4298.13124.39175.68
Book Value Per Share
1.051.000.961.241.882.55
Tangible Book Value
198.67130.6668.1387.6132.05179.49
Tangible Book Value Per Share
1.051.000.961.241.872.55
Machinery
1.531.531.531.461.420.5
Leasehold Improvements
0.310.310.310.310.31-
SEC Filings: 10-K · 10-Q